StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX)

StockNews.com assumed coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) in a report released on Wednesday morning. The firm issued a hold rating on the medical research company’s stock. Accelerate Diagnostics Stock Performance Shares of NASDAQ:AXDX opened at $1.52 on Wednesday. The company has a market cap of $35.99 million, a P/E ratio […]

Leave a Reply

Your email address will not be published.

Previous post Royal Bank of Canada Reiterates Outperform Rating for COMPASS Pathways (NASDAQ:CMPS)
Next post DA Davidson Initiates Coverage on Meta Platforms (NASDAQ:META)